Introduction to a review series on strategies to improve GVL effects

Authors :: Robert Zeiser
Source :: Blood. 131:1039-1039
Publication Year :: 2018
Publisher :: American Society of Hematology, 2018.
Abstract: Robert Zeiser, MD, and Michel Sadelain, MD, PhD, share some highlights of this review series. Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative approach for a large group of hematological malignancies, and it relies heavily on graft-versus-leukemia (GVL) effects. Relapse